Faron Pharmaceuticals Oy (HEL:FARON)
2.050
+0.005 (0.24%)
At close: Oct 9, 2025
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of €228.13 million as of October 9, 2025. Its market cap has decreased by -15.48% in one year.
Market Cap
228.13M
Enterprise Value
236.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.05
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 76.45M to 228.13M, an increase of 198.41%. That is a compound annual growth rate of 11.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 228.94M | -11.73% |
Dec 31, 2024 | 259.36M | 7.28% |
Dec 29, 2023 | 241.77M | 19.52% |
Dec 30, 2022 | 202.28M | 19.31% |
Dec 31, 2021 | 169.54M | 24.58% |
Dec 31, 2020 | 136.09M | 1.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Nov 17, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Orion Oyj | 9.85B |
Terveystalo Oyj | 1.25B |
Revenio Group Oyj | 625.17M |
Pihlajalinna Oyj | 355.19M |
Oriola Oyj | 211.18M |
Nightingale Health Oyj | 152.21M |
Nexstim | 104.87M |
Nanoform Finland Oyj | 98.01M |